Savara (SVRA) FCF Margin (2013 - 2020)

Savara's (SVRA) quarterly FCF Margin came in at 1230500.0% in Q4 2020, down 46755.27% on a QoQ basis from 2626.17% in Q3 2020.

Savara (SVRA) FCF Margin (2013 - 2020) Analysis & Trends

Savara (SVRA) has 5 years of FCF Margin data on file, last reported at 1230500.0% in Q4 2020.

On a quarterly basis, FCF Margin changed N/A year-over-year to 1230500.0% in Q4 2020; TTM through Mar 2022 was 3896000.0%, a N/A change from a year earlier, with the FY2020 full-year figure at 15518.68%, changed N/A from the prior year.
FCF Margin for Q4 2020 stood at 1230500.0%, down from 2626.17% in the prior quarter.
Over the last five years, FCF Margin for SVRA reached as high as 8161.7% in Q2 2017 and fell as low as 1230500.0% in Q4 2020.
Historically, FCF Margin has averaged 205828.93% across 3 years, with a median of 2857.23% in 2020.
On a YoY basis, FCF Margin climbed as much as 3631231 bps in 2016 and fell as far as 3631231 bps in 2016.
Year by year, FCF Margin stood at 547.5% in 2016, then soared by 1591 bps to 8161.7% in 2017, then tumbled by 15177 bps to 1230500.0% in 2020.
Per Business Quant data, the three most recent FCF Margin figures were 1230500.0% in Q4 2020, 2626.17% in Q3 2020, and 8161.7% in Q2 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	FCF Margin (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	10.45%
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	43.35%
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	23.53%
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Savara	1.24 Bn	1.24 Bn	-	-

Download Data